Phase II-V Oncology Archive

A building with a stone facade displays a sign that reads
Abhimanyu Ghose, M.D., F.A.C.P.
A building with a stone facade displays a sign that reads
A Phase 2, Single-Arm Trial of Relacorilant in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (TRIDENT)
A building with a stone facade displays a sign that reads
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
A building with a stone facade displays a sign that reads
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
A building with a stone facade displays a sign that reads
IDE196 (Darovasertib) in Combination With Crizotinib Versus Investigator’s Choice of Treatment as First-line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma (DAR-UM-2)